Communicating About Nicotine Reduction in Cigarettes
Communicating About Nicotine and Differential Risks of Tobacco Products in Priority Populations
2 other identifiers
interventional
1,230
1 country
2
Brief Summary
The goal of this clinical trial is to learn how a messaging campaign about reduced nicotine cigarettes and policy, combined with the use of very low nicotine cigarettes (VLNCs), affects smoking behavior and attitudes among adult smokers. The study also aims to assess the efficacy of the messages in different populations, including smokers with past-month serious psychological distress (SPD), low socioeconomic status (SES), and those in neither category. The primary hypothesis is: exposure to messages in combination with VLNC use will lead to less cigarettes use compared to VLNCs without messages. Researchers will compare: The effects of receiving VLNCs with messages (treatment group) to receiving VLNCs without messages (control group). Participants will: Complete a baseline survey and be randomly assigned to one of two groups: treatment (VLNCs + messages) or control (VLNCs only). Attend weekly study visits for surveys, breath samples, and receive supply of VLNCs , either with or without the messaging campaign. Complete brief daily surveys through text messages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2025
CompletedStudy Start
First participant enrolled
September 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2029
October 29, 2025
October 1, 2025
3.4 years
December 25, 2024
October 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cigarettes per day
Number of cigarettes smoked per day (study and non-study cigarettes). * Averaged number of cigarettes smoked based on 7 days' daily logs submitted through text-based survey during the last week of the trial. * Response: integer indicating number per day.
Week 4 of the trial (post randomization)
Secondary Outcomes (7)
Use of other tobacco products
Week 4 of the trial (post randomization)
Use of cessation medications
Week 4 of the trial (post randomization)
Forgoing cigarettes
Through study completion, up to 4 weeks
Making a quit attempt
Through study completion, up to 4 weeks
Perceived risk of smoking VLNCs
Week 4 of the trial (post randomization)
- +2 more secondary outcomes
Study Arms (2)
VLNC with message campaign
EXPERIMENTALParticipants in this arm will receive VLNCs during weekly visits and be exposed to messaging about VLNCs and reduced nicotine policy through multiple formats, including inserts placed in cigarette packs, printed advertisements, and videos presented during weekly visits.
VLNC only
OTHERParticipants in this arm will receive VLNCs during weekly visits but will not receive any messaging related to cigarettes or reduced nicotine policy. Instead, they will only be exposed to control messages, such as advertisements for bottled water, during weekly visits.
Interventions
Participants will be exposed to messaging about VLNCs and reduced nicotine policy through multiple formats, including inserts placed in cigarette packs, printed advertisements, and video materials presented during their weekly visits.
Participants will be exposed to control messages, such as advertisements for bottled water, during their weekly visits.
Eligibility Criteria
You may qualify if:
- Age 21+ years
- Current smoker (self-report as having smoked 100 cigarettes in their lifetime and currently smoking on 27+ days out of past 30, expired breath carbon monoxide \[CO\] ≥6ppm to assess regular smoking)
- Can speak, read, and write in English
- Available for period of study
- Willing to try novel research cigarettes
You may not qualify if:
- Pregnancy or lactation
- Member of the same household as a study subject
- Unwilling to use research cigarettes as part of the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Georgia State Universitylead
- Emory Universitycollaborator
- University of South Carolinacollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (2)
Georgia State university
Atlanta, Georgia, 30303, United States
Emory University
Atlanta, Georgia, 30322, United States
Related Publications (1)
Pei D, Juris A, Nkansah P, Thrasher JF, Giordano NA, Henderson KC, Spears CA, Ashley DL, Mallory VC, Adeniji FP, Foster JD, Ni W, Kodriati N, Ogunnaike A, Pechacek TF, Kirpich A, Popova L. Nicotine Intervention and Communication for Empowering Reduction (NICER): study protocol for a randomized controlled trial among priority populations of people who smoke. Trials. 2025 Nov 17;26(1):514. doi: 10.1186/s13063-025-09216-8.
PMID: 41250122DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 25, 2024
First Posted
January 22, 2025
Study Start
September 11, 2025
Primary Completion (Estimated)
January 31, 2029
Study Completion (Estimated)
January 31, 2029
Last Updated
October 29, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share